Effectiveness and Safety of Iguratimod in Treating Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

Objectives: We aimed to assess the effectiveness and safety of iguratimod (IGU) in treating primary Sjögren’s syndrome (pSS) by meta-analysis. Methods: Eight databases and two clinical trial websites were searched from conception to August 10, 2020, for relevant randomized controlled trials (RCTs) o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Pu, Jincheng, Wang, Xuan, Riaz, Farooq, Zhang, Tongyangzi, Gao, Ronglin, Pan, Shengnan, Wu, Zhenzhen, Liang, Yuanyuan, Zhuang, Shuqi, Tang, Jianping
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017188/
https://ncbi.nlm.nih.gov/pubmed/33815105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.621208
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki